Compare PGEN & DSGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PGEN | DSGR |
|---|---|---|
| Founded | 1998 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2013 | 1995 |
| Metric | PGEN | DSGR |
|---|---|---|
| Price | $4.24 | $27.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | $8.33 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 3.0M | 52.8K |
| Earning Date | 05-13-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 212.50 |
| EPS | N/A | ★ 0.01 |
| Revenue | $230,981,000.00 | ★ $1,980,023,000.00 |
| Revenue This Year | $1,115.92 | $5.35 |
| Revenue Next Year | $81.04 | $3.79 |
| P/E Ratio | ★ N/A | $2,715.00 |
| Revenue Growth | N/A | ★ 9.75 |
| 52 Week Low | $1.28 | $19.02 |
| 52 Week High | $5.47 | $33.80 |
| Indicator | PGEN | DSGR |
|---|---|---|
| Relative Strength Index (RSI) | 52.41 | 47.85 |
| Support Level | $3.97 | $26.94 |
| Resistance Level | $4.40 | $27.73 |
| Average True Range (ATR) | 0.25 | 0.49 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 30.98 | 21.04 |
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
Distribution Solutions Group Inc is a specialty distribution company providing value-added distribution solutions to the maintenance, repair and operations (MRO), original equipment manufacturer (OEM) and industrial technology markets. The company operates through four reportable segments: Lawson, TestEquity, Gexpro Services and Canada Branch Division. Lawson distributes specialty products and services to the industrial, commercial, institutional and government MRO marketplace. TestEquity, which generates maximum revenue, distributes test and measurement equipment and solutions, industrial and electronic production supplies and vendor managed inventory programs. Gexpro Services is a supply chain solutions provider. The company generates majority of its revenue from United States.